Dl-Tryptophan

Dl-Tryptophan

SCHEMBL22635845

CCC(C)C(N)C(=O)O.CCC(C)C(N)C(=O)O.NC(Cc1c[nH]c2ccccc12)C(=O)O.NC(Cc1ccc(O)cc1)C(=O)O.NC(Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.64
▸ MAPT P10636 3/20 0.64
▸ KMT2A Q03164 3/20 0.64
▸ LMNA P02545 2/20 0.64
▸ TSHR P16473 2/20 0.64
▸ BLM P54132 2/20 0.64
▸ PMP22 Q01453 2/20 0.64
▸ MEN1 O00255 2/20 0.64
▸ MPO P05164 1/20 0.64
▸ HIF1A Q16665 1/20 0.64
▸ HTR2A P28223 3/20 0.55
▸ HTR1A P08908 2/20 0.55
▸ HTR2C P28335 2/20 0.55
▸ SLC6A4 P31645 2/20 0.55
▸ HTR7 P34969 2/20 0.55
▸ HTR2B P41595 2/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ ADORA3 P0DMS8 1/20 0.55
▸ ALOX15 P16050 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dl-Tryptophan SCHEMBL27537413 0.94 KMT2A (0.57) KDM4EMAPTKMT2ALMNATSHR
Dl-Tryptophan SCHEMBL6473524 0.92 KMT2A (0.54) KDM4EMAPTKMT2ALMNATSHR
Tryptophan SCHEMBL6473526 0.92 KMT2A (0.54) KDM4EMAPTKMT2ALMNATSHR
Tryptophan SCHEMBL2060360 0.92 KDM4E (0.76) KDM4EMAPTKMT2ALMNATSHR
Dl-Tryptophan SCHEMBL4400705 0.92 KDM4E (0.76) KDM4EMAPTKMT2ALMNATSHR
Dl-Tryptophan SCHEMBL27895091 0.91 KDM4E (0.68) KDM4EMAPTKMT2ALMNATSHR
Dl-Tryptophan SCHEMBL17889024 0.90 KDM4E (0.67) KDM4EMAPTKMT2ALMNATSHR
Tryptophan SCHEMBL5605972 0.90 KDM4E (0.67) KDM4EMAPTKMT2ALMNATSHR
Tryptophan SCHEMBL5605980 0.90 KDM4E (0.67) KDM4EMAPTKMT2ALMNATSHR
Tryptophan SCHEMBL9449482 0.90 KDM4E (0.73) KDM4EMAPTKMT2ALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11613746-B2 Methods for developing virus protein specific capture agents, capture agents, and methods of using the capture agents THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2023-03-28 — — US claimed
US-20230021979-A1 METHODS FOR DEVELOPING VIRUS PROTEIN-SPECIFIC CAPTURE AGENTS, CAPTURE AGENTS, AND METHODS OF USING THE CAPTURE AGENTS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2023-01-26 — — US claimed
US-20200354713-A1 METHODS FOR DEVELOPING VIRUS PROTEIN SPECIFIC CAPTURE AGENTS, CAPTURE AGENTS, AND METHODS OF USING THE CAPTURE AGENTS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2020-11-12 — — US claimed
US-11613746-B2 Methods for developing virus protein specific capture agents, capture agents, and methods of using the capture agents THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2023-03-28 — — US disclosed
US-20230021979-A1 METHODS FOR DEVELOPING VIRUS PROTEIN-SPECIFIC CAPTURE AGENTS, CAPTURE AGENTS, AND METHODS OF USING THE CAPTURE AGENTS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2023-01-26 — — US disclosed
US-20200354713-A1 METHODS FOR DEVELOPING VIRUS PROTEIN SPECIFIC CAPTURE AGENTS, CAPTURE AGENTS, AND METHODS OF USING THE CAPTURE AGENTS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2020-11-12 — — US disclosed
Send feedback